Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Immunoprecise Antibodies Ltd (NQ: IPA ) 0.4175 -0.0595 (-12.47%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Immunoprecise Antibodies Ltd < Previous 1 2 3 4 5 6 7 Next > IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology March 07, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024 March 04, 2024 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies (NASDAQ:IPA) Is Changing How We Look At The Complex World Of Antibody Discovery February 13, 2024 Via ACCESSWIRE Earnings Preview For ImmunoPrecise Antibodies December 13, 2023 Via Benzinga ImmunoPrecise Antibodies (NASDAQ: IPA) Is Changing How We Look At The Complex World Of Antibody Discovery February 12, 2024 Even though we speak, listen, read and write every day, language is incredibly complex and ever-evolving. Context is critical to understanding. In the English language, there are a plethora of words... Via Benzinga ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms January 10, 2024 Via ACCESSWIRE ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms January 09, 2024 ImmunoPrecise Antibodies (NASDAQ: IPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently Via Benzinga IPA Stock Earnings: ImmunoPrecise Antibodies Beats EPS, Beats Revenue for Q2 2024 December 14, 2023 IPA stock results show that ImmunoPrecise Antibodies beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace IPA Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2024* December 14, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire Earnings Scheduled For December 14, 2023 December 14, 2023 Companies Reporting Before The Bell • Live Ventures (NASDAQ:LIVE) is estimated to report earnings for its fourth quarter. • Jabil (NYSE:JBL) is projected to report earnings for its first quarter. Via Benzinga IPA Announces Closing of $1.265 Million Public Offering of Common Shares December 08, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14 December 07, 2023 Via ACCESSWIRE Gold Moves Higher; Campbell Soup Earnings Top Expectations December 06, 2023 U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73. Via Benzinga Topics Stocks Exposures US Equities Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session December 06, 2023 Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results. Via Benzinga Why ImmunoPrecise Antibodies (IPA) Stock Is Down 20% Today December 06, 2023 ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) shares are trading lower by 23% to $1.19 Wednesday afternoon after the company announced pricing of a $1.1 million public offering of common shares at Via Benzinga Crude Oil Down 4%; Pharvaris Shares Spike Higher December 06, 2023 U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell,... Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities US Stocks Higher; Private Payrolls Rise By 103,000 In November December 06, 2023 U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28%... Via Benzinga Topics Stocks Exposures US Equities Why Is Carbon Revolution (CREV) Stock Down Today? December 06, 2023 Carbon Revolution stock is falling on Wednesday after shares of CREV gained yesterday with plans for a business update conference call. Via InvestorPlace Why Is ImmunoPrecise Antibodies (IPA) Stock Down 39% Today? December 06, 2023 ImmunoPrecise Antibodies stock is falling on Wednesday after the company announced a $1.1 million public offering for shares of IPA. Via InvestorPlace Why SentinelOne Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket December 06, 2023 Shares of SentinelOne, Inc. (NYSE: S) rose sharply in pre-market trading after the company reported stronger-than-expected results for its third quarter and raised its annual revenue outlook. Via Benzinga ImmunoPrecise Antibodies Welcomes Mitch Levine To Its Board Of Directors, To Announce Quarterly Results On December 14 December 06, 2023 ImmunoPrecise Antibodies (NASDAQ: IPA) (“IPA”), a leading company in AI-driven biotherapeutic research and technology, has recently announced important changes to its Board of Directors and upcoming... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday December 06, 2023 It's time to dive into the biggest pre-market stock movers for Wednesday with a breakdown of all the latest news this morning! Via InvestorPlace IPA Announces Pricing of $1.1 Million Public Offering of Common Shares December 06, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire IPA Announces Proposed Public Offering of Common Shares December 05, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise Antibodies Ltd. Announces Key Board and Board Committee Chair Appointments and Second Quarter 2024 Earnings Release Call November 27, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire ImmunoPrecise’s BioStrand(R) Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery November 22, 2023 Via ACCESSWIRE ImmunoPrecise's BioStrand® Unifies Diverse Data Modalities, Launches AI-Driven Platform For Enhanced Drug Discovery November 20, 2023 ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, has announced that its subsidiary, BioStrand®, has launched an advanced Retrieval Augmented... Via Benzinga BioStrand® Unveils a Revolutionary Approach to Biological Sequence Retrieval: A Fusion of Natural Language Processing and Database Research November 13, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire EXCLUSIVE: Antibody-Discovery Platform Provider ImmunoPrecise's Subsidiary Highlights Approach to Biological Sequence Retrieval November 13, 2023 ImmunoPrecise Antibodies Ltd's (NASDAQ: IPA) subsidiary BioStrand has published a preprint of its white paper titled "New Paradigm for Biological Sequence Retrieval Inspired by Natural Via Benzinga IPA’s Subsidiary, BioStrand, Provides an Update on LENSai™ October 25, 2023 From ImmunoPrecise Antibodies Ltd. Via Business Wire < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
